CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-23 | Luqman Elisa V Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +35,719 | $2.11 | $75K | 264,832 |
| 2024-01-23 | Abdullahi Khullani VP of Revenue and Strategy | Grant or award · Stock Options (Right to Buy) | +238,128 | $2.11 | $502K | 304,128 |
| 2024-01-23 | Philibert Robert Chief Medical Officer | Grant or award · Stock Options (Right to Buy) | +142,876 | $2.11 | $301K | 805,465 |
| 2024-01-23 | Hosseinion Warren Director | Grant or award · Stock Options (Right to Buy) | +35,719 | $2.11 | $75K | 502,195 |
| 2024-01-23 | Dogan Timur Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +238,128 | $2.11 | $502K | 435,467 |
| 2024-01-23 | Dogan Timur Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +476,256 | $2.11 | $1.0M | 1,433,958 |
| 2024-01-23 | Dogan Meeshanthini Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +476,256 | $2.11 | $1.0M | 1,433,958 |
| 2024-01-23 | Dogan Meeshanthini Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +238,128 | $2.11 | $502K | 435,467 |
| 2023-12-31 | Levy Oded Director | Option exercise | +5,020 | $2.49 | $12K | 62,793 |
| 2023-12-31 | Levy Oded Director | Option exercise · Restricted Stock Units | −0 | |||
| 2023-12-31 | Sim Brandon Director | Option exercise | +5,020 | $2.49 | $12K | 62,793 |
| 2023-12-31 | Sim Brandon Director | Option exercise · Restricted Stock Units | −0 | |||
| 2023-12-31 | Intrater James Director | Option exercise | +5,020 | $2.49 | $12K | 62,793 |
| 2023-12-31 | Intrater James Director | Option exercise · Restricted Stock Units | −0 | |||
| 2023-12-31 | Levy Oded Director | Option exercise | +5,020 | $2.49 | $12K | 62,793 |
| 2023-12-31 | Levy Oded Director | Purchase · Restricted Stock Units | −0 | |||
| 2023-12-31 | Lau Stanley K. Director | Option exercise | +1,606 | $2.49 | $4K | 85,585 |
| 2023-12-31 | Lau Stanley K. Director | Option exercise | +5,020 | $2.49 | $12K | 90,605 |
| 2023-12-31 | Lau Stanley K. Director | Option exercise · Restricted Stock Units | −0 | |||
| 2023-12-31 | Lau Stanley K. Director | Option exercise · Restricted Stock Units | −0 |
Page 4 of 7 · 137 trades